AzTrials
AzTrials

VertigoPhase 2NCT00000359

Treatments for Benign Paroxysmal Positional Vertigo (BPPV)

A Phase 2 study testing Canalith repositioning maneuver (Epley maneuver), Semont maneuver and Brandt-Daroff exercises in people with Vertigo, run by Baylor College of Medicine at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, the Brandt-Daroff… Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Vertigo
What is being tested?
Canalith repositioning maneuver (Epley maneuver), Semont maneuver and Brandt-Daroff exercises
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
150 participants
Where
1 siteUnited States
Study dates
Oct 1998to Jun 2003
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients may be eligible for this study if they:
  • Are at least 21 years old.
  • Have a diagnosis of unilateral posterior semicircular canal BPPV according to established clinical test criteria.
  • Have functional to normal range of motion of the neck and the back.

Who cannot join

  • Patients will not be eligible for this study if they:
  • Have a history of prior ear surgery or prior treatment for BPPV.
  • Have an orthopedic or connective tissue disorder that impairs functional neck or trunk range of motion.
  • Have a significant neurological disorder or spinal cord damage.
  • Are on vestibular suppressant medications.
  • Have Meniere's disease or acoustic neuromas.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Baylor College of Medicine

    Houston, Texas, 77030

Other trials in United States

About this study

The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, the Brandt-Daroff exercises and nonspecific vestibular habituation exercises. These procedures involve exercises and head manipulations. Vertigo intensity and frequency, the presence/absence of slow-phase eye movements, the degree of dizziness handicap and acts of daily living (ADL) were assessed. The study also ascertained the effects of co-morbid conditions on the response to treatment. While BPPV is a common and significant public health problem that has been recognized for several decades, this is the first systematic study of the relative treatment efficacy of different physical treatment modalities for this disorder.

Conditions
Vertigo
Being tested
Canalith repositioning maneuver (Epley maneuver), Semont maneuver, Brandt-Daroff exercises, Vestibular habituation exercises, ShamManeuver
Keywords
Physical Therapy, Vertigo, rehabilitation, occupational therapy
Medical subject headings
Vertigo

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Canalith repositioning maneuver (Epley maneuver)Behavioural

    Also called CRP, Epley maneuver

    Standard passive motion of the head: Dix-Hallpike maneuver, turn head to opposite side, roll over, sit up.

  • Semont maneuverBehavioural

    Also called Liberatory maneuver

    Sidelying maneuver, flip over 180 deg, sit up.

  • Brandt-Daroff exercisesBehavioural

    Active exercise. Sidelying to involved side, sidelying to uninvolved side, sit up.

  • Vestibular habituation exercisesBehavioural

    Head shaking exercises in pitch, roll, yaw and circumduction. Titrating from 2 repetitions per exercise to 20 repetitions per exercise, as tolerated.

  • ShamManeuverBehavioural

    Passive movement of the head

Study groups in NCT00000359
Study groupRoleWhat they receive
Canalith repositioning maneuverExperimentalRepositioning treatment for posterior canal BPPV
Receives: Behavioral: Canalith repositioning maneuver (Epley maneuver)
Modified Epley maneuverExperimentalNot described
Receives: Behavioral: Vestibular habituation exercises
ShamSham comparatorThe subject sat in a chair; the head was passively tilted downward, turned away from the involved side, turned back to center, upward, away from the involved side, twice, slowly.
Receives: Behavioral: ShamManeuver
Liberatory maneuverActive comparatorThe standard liberatory maneuver (also known as the Semont maneuver) was used.
Receives: Behavioral: Semont maneuver
Brandt Daroff exerciseActive comparatorModified Brandt Daroff exercise performed as a self-liberatory exercise.
Receives: Behavioral: Brandt-Daroff exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Vertigo

    Measured: 6 month s

Secondary outcomes (1)
  1. Balance

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Nov 1999 (estimated)
  2. Study startOct 1998
  3. Primary completionJun 2003
  4. Study completionJun 2003

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00000359
Sponsor's protocol ID
NIDCD-1156
Other IDs
R01DC003602, 1R01DC003602-01A1
Status last verified
Jul 2012
First submitted
2 Nov 1999
Last updated
26 Jul 2012
Results posted
No
Data monitoring committee
No

Publications

  • Cohen HS. Side-lying as an alternative to the Dix-Hallpike test of the posterior canal. Otol Neurotol. 2004 Mar;25(2):130-4. doi: 10.1097/00129492-200403000-00008.

    PubMed 15021771
  • Cohen HS, Kimball KT, Stewart MG. Benign paroxysmal positional vertigo and comorbid conditions. ORL J Otorhinolaryngol Relat Spec. 2004;66(1):11-5. doi: 10.1159/000077227.

    PubMed 15103195
  • Cohen HS, Kimball KT. Treatment variations on the Epley maneuver for benign paroxysmal positional vertigo. Am J Otolaryngol. 2004 Jan-Feb;25(1):33-7. doi: 10.1016/j.amjoto.2003.09.010.

    PubMed 15011204
  • Cohen HS, Kimball KT. Effectiveness of treatments for benign paroxysmal positional vertigo of the posterior canal. Otol Neurotol. 2005 Sep;26(5):1034-40. doi: 10.1097/01.mao.0000185044.31276.59.

    PubMed 16151355

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Canalith repositioning maneuver (Epley maneuver), Semont maneuver and Brandt-Daroff exercises in people with Vertigo, run by Baylor College of Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jul 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Vertigo (time frame: 6 month s). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00000359, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in